J 2019

Epidemiological analyses to inform stroke clinical practice guidelines development

LÍČENÍK, Radim; Jitka KLUGAROVÁ; Andrea POKORNÁ; Monika BEZDĚKOVÁ; Jiří JARKOVSKÝ et al.

Základní údaje

Originální název

Epidemiological analyses to inform stroke clinical practice guidelines development

Autoři

LÍČENÍK, Radim; Jitka KLUGAROVÁ; Andrea POKORNÁ; Monika BEZDĚKOVÁ; Jiří JARKOVSKÝ ORCID; Petra BÚŘILOVÁ; Tomáš NEČAS; Jan MUŽÍK; Silvie ŠEBESTOVÁ; Dana DOLANOVÁ; Martin HUNČOVSKÝ; Ladislav DUŠEK a Miloslav KLUGAR

Vydání

International Journal of Evidence-Based Healthcare, Wolters Kluwer/Lippincott Williams & Wilkins, 2019, 1744-1609

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.930

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/19:00110132

Organizační jednotka

Lékařská fakulta

UT WoS

000511111600017

EID Scopus

2-s2.0-85069284881

Klíčová slova anglicky

aortic valve disease; atrial fibrillation; atrial septal defect; clinical practice guidelines; endocarditis; flutter; intravenous thrombolysis; ischaemic stroke; mechanical thrombectomy; secondary prevention

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 5. 2020 09:29, Mgr. Tereza Miškechová

Anotace

V originále

Stroke is one of the leading causes of mortality and the leading cause of functional impairment and cognitive deficits worldwide. It is important that clinical practice guidelines development is based on robust statistical and epidemiological data and their analysis throughout the whole process of guidelines development and implementation. The aim of this short communication is to analyse epidemiology of prevalence and incidence of ischaemic stroke, its main causes, brain imaging using MRI, recanalization therapies, secondary prevention with antiplatelet and anticoagulants, mortality data and to inform development of stroke clinical practice guidelines in the Czech Republic. The main analysed diagnosis was I63 (cerebral infarction) and secondary diagnoses were: I48 (atrial fibrillation and flutter), I35.9 (nonspecified aortic valve disease), Q21.1 (atrial septal defect) or I33.0 (acute and subacute endocarditis). We have also analysed use of brain imaging with MRI, recanalization treatment using intravenous thrombolysis and mechanical thrombectomy, stroke secondary prevention with antiplatelet drugs and anticoagulation as well as hospital admissions and mortality. In total, 159 344 patients were diagnosed with an ischaemic stroke from 2015 to 2017. Average prevalence of ischaemic stroke in the Czech Republic is 54.9 patients per 100 000. 22.2% of patients with stroke received intravenous thrombolysis or mechanical thrombectomy in 2017.